Katkin Keith bought ELDN
January 10, 2026 · Form 4 insider transaction
Katkin Keith bought 8,575 shares of Eledon Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,575
Price
$0.00
Total value
N/A
InsiderKatkin Keith
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 10, 2026
Filing dateJanuary 16, 2026
Shares owned after8,575
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares issuable on settlement of restricted stock units ("RSUs") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026.